Navigation Links
Boston Scientific Announces First Quarter Special Items
Date:4/15/2009

to be incorrect, or if certain risks or uncertainties materialize, actual results could vary materially from the expectations and projections expressed or implied by our forward-looking statements. These factors, in some cases, have affected and in the future (together with other factors) could affect our ability to implement our business strategy and may cause actual results to differ materially from those contemplated by the statements expressed in this press release. As a result, readers are cautioned not to place undue reliance on any of our forward-looking statements.

Factors that may cause such differences include, among other things: future economic, competitive, reimbursement and regulatory conditions; new product introductions; demographic trends; intellectual property; litigation; financial market conditions; and, future business decisions made by us and our competitors. All of these factors are difficult or impossible to predict accurately and many of them are beyond our control. For a further list and description of these and other important risks and uncertainties that may affect our future operations, see Part I, Item 1A - Risk Factors in our most recent Annual Report on Form 10-K filed with the Securities and Exchange Commission, which we may update in Part II, Item 1A - Risk Factors in Quarterly Reports on Form 10-Q we have filed or will file thereafter. We disclaim any intention or obligation to publicly update or revise any forward-looking statements to reflect any change in our expectations or in events, conditions, or circumstances on which those expectations may be based, or that may affect the likelihood that actual results will differ from those contained in the forward-looking statements. This cautionary statement is applicable to all forward-looking statements contained in this document.

    CONTACT:  Paul Donovan                     Larry Neumann
              508-650-8541 (office)            5
'/>"/>
SOURCE Boston Scientific
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3 4 5

Related biology technology :

1. Boston Scientific Launches New Coronary Imaging Catheter
2. Moodys Raises Boston Scientifics Rating Outlook to Stable
3. BG Medicine Signs Collaborative Research Agreement with the National Heart, Lung and Blood Institute (NHLBI), and Boston University
4. Nektar Therapeutics President and CEO, Howard W. Robin, to Present at the 29th Annual Cowen and Company Healthcare Conference in Boston
5. Boston LASIK Eye Surgery Expert Dr. Peter Rapoza Joins Select Group of Doctors in Trusted LASIK Surgeons Directory
6. Boston Scientific Resolves Outstanding Litigation Matter, Finalizes Goodwill Impairment Charge
7. Boston Scientific Announces Japanese Approval for TAXUS(R) Liberte(R) Drug-Eluting Stent System
8. Biotechnology Veteran Michael Webb Joins Boston-based Investment Bank as Senior Advisor
9. Boston Scientific Acquires Labcoat Limited
10. FDA Approves Boston Scientifics Express(R) SD Renal Stent System
11. Kendle to Present at the 2008 Raymond James Boston Fall Investors Conference
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:4/16/2015)... and MENLO PARK, Calif. ... (OTCQX: DMPI) (DelMar and the Company), a biopharmaceutical ... in new orphan drug indications, today announced that the ... as a clinical trial site for the ongoing, multicenter ... glioblastoma multiforme (GBM), the most common and deadly form ...
(Date:4/16/2015)... BETHESDA, Md. , April 16, 2015 /PRNewswire/ ... Bio"), a biotechnology company developing non-toxic DCVax® personalized ... has been included in the Loncar Cancer Immunotherapy ... help investors better track the immunotherapy field within ... founders have selected "the top 25 companies" in ...
(Date:4/16/2015)... Modality Solutions, a company that delivers ... industries, is pleased to announce its President, Gary ... Cold Chain IQ - Temperature Control Logistics and ... Global Cold Chain Connections, is dedicated to sharing ... pharmaceutical and healthcare supply chains. , Cold ...
(Date:4/15/2015)... England , April 16, 2015 ... developing novel biological drugs to treat cancer and ... and development arm of AstraZeneca, today announced that ... Under the terms of the agreement, Immunocore ... MedImmune,s investigational checkpoint inhibitors MEDI4736 (anti-PD-L1) and/or tremelimumab ...
Breaking Biology Technology:DelMar Pharmaceuticals Adds Fourth Clinical Trial Site in Phase I/II Multicenter Study of VAL-083 for Recurrent Malignant Glioma 2DelMar Pharmaceuticals Adds Fourth Clinical Trial Site in Phase I/II Multicenter Study of VAL-083 for Recurrent Malignant Glioma 3DelMar Pharmaceuticals Adds Fourth Clinical Trial Site in Phase I/II Multicenter Study of VAL-083 for Recurrent Malignant Glioma 4DelMar Pharmaceuticals Adds Fourth Clinical Trial Site in Phase I/II Multicenter Study of VAL-083 for Recurrent Malignant Glioma 5NW Bio Included In New Index Of The "Top 25 Cancer Immunotherapy Companies" 2NW Bio Included In New Index Of The "Top 25 Cancer Immunotherapy Companies" 3Modality Solutions Gary Hutchinson Named Columnist for Cold Chain IQ 2Modality Solutions Gary Hutchinson Named Columnist for Cold Chain IQ 3Immunocore and MedImmune Announce New Collaboration to Conduct Immuno-oncology Combination Trails in Melanoma 2Immunocore and MedImmune Announce New Collaboration to Conduct Immuno-oncology Combination Trails in Melanoma 3Immunocore and MedImmune Announce New Collaboration to Conduct Immuno-oncology Combination Trails in Melanoma 4Immunocore and MedImmune Announce New Collaboration to Conduct Immuno-oncology Combination Trails in Melanoma 5Immunocore and MedImmune Announce New Collaboration to Conduct Immuno-oncology Combination Trails in Melanoma 6
... two British education officals visited Madison to determine ... a time when many Wisconsin leaders are studying ... regions, it is ironic that across the Atlantic, ... and have turned to Wisconsin to export an ...
... -- Aurora Health Care is planning to open a ... new digital hospital will include the latest in digital ... physicians will benefit from enterprise storage and distribution of ... , ,Aurora Health Care established in 1984 is ...
... and political expertise motivates Wisconsins State Senator to trim ... and services. We want to stimulate venture ... to qualified venture funds as well as expand the ... create a bi-partisan effort to pass an end-to-end economic ...
Cached Biology Technology:Aurora Selects New Imaging Technology 2WTN Interview: Senator Ted Kanavas 2WTN Interview: Senator Ted Kanavas 3WTN Interview: Senator Ted Kanavas 4WTN Interview: Senator Ted Kanavas 5WTN Interview: Senator Ted Kanavas 6WTN Interview: Senator Ted Kanavas 7WTN Interview: Senator Ted Kanavas 8
(Date:4/17/2015)... 2015 Increasing adoption ... advancement to drive biometric systems market in ... According to a recently released TechSci ... ", biometric systems market in Saudi ... at CAGR of over 22% through 2020. The ...
(Date:4/14/2015)...  HYPR Corp. today announced it has joined ... tm , an industry consortium transforming online authentication ... technology and collaborate to deliver open specifications for ... and private, and easier to use. ... sensitive user information and eliminates the dependency on ...
(Date:4/14/2015)... 2015 NXT-ID, Inc. (NASDAQ: NXTD ) ... on the growing mobile commerce market, announces that its ... New York Design Awards under the category  ,Product Design ... Design Awards are part of a global multi-disciplinary awards ... from the marketplace, industry and judging panel. Winners will ...
Breaking Biology News(10 mins):Saudi Arabia Biometric Systems Market to Grow at 22% Through 2020, Says TechSci Research 2Saudi Arabia Biometric Systems Market to Grow at 22% Through 2020, Says TechSci Research 3HYPR Corp. Joins the FIDO Alliance 2HYPR Corp. Joins the FIDO Alliance 3NXT-ID's Wocket Smart Wallet Nominated for 2015 New York Design Awards in 'Product Design- Technology' 2NXT-ID's Wocket Smart Wallet Nominated for 2015 New York Design Awards in 'Product Design- Technology' 3
... New Mexico, March 3, 2010Two teams of researchersincluding Los ... Sydeaka Watson, and James Szingerhave announced an HIV vaccination ... and depth of immune responses in rhesus monkeys. Rhesus ... testing HIV vaccines. The research appeared in two ...
... release is available in Spanish . ... nutrition savvyplus physical fitness skillsare emerging from scientific studies ... example, investigators Craig A. Johnston, John P. Foreyt and ... of their earlier studies in which many of their ...
... Far from being a food spoiler, the fluorescent lighting ... fresh spinach, scientists are reporting. The finding could lead ... value of spinach and perhaps other veggies, they suggest ... Agricultural and Food Chemistry . Gene Lester, Donald ...
Cached Biology News:HIV vaccine strategy expands immune responses 2Kids lose pounds, gain fitness in Houston study 2
Rabbit Polyclonal antibody to Perilipin Applications: This antibody is useful for Western blot anlaysis where a band at ~60 kDa is seen....
Conveniently document gels, films and membranes with a high quality thermal printer. , Compact, footprint printer , Supplies 256 gray scale for high resolution, archive-quality thermal film prints...
... designer enzyme that enables RT-PCR in ... enzyme allows reverse transcription and PCR ... temperatures (65C), which helps to remove ... results in highly stringent, accurate annealing ...
... Mch3 Lyophilized solid. ... regulation and kinetics, cleavage of target substrates, and inhibitor ... One unit is defined as the amount ... Cat. No. 235400 per hour at 37 C at ...
Biology Products: